Clinical Trial Update: Exposure to Neurotoxins as Risk Factors for ALS

View source ↗

Summary

This clinical trial update discusses a study examining exposure to neurotoxins as potential risk factors for developing amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: ALS | Status: COMPLETED